gabexate has been researched along with Abdominal Injuries in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Abdominal Injuries: General or unspecified injuries involving organs in the abdominal cavity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H | 1 |
| Song, Q | 1 |
| Lv, F | 1 |
| Wang, S | 1 |
| Wang, Y | 1 |
| Li, X | 1 |
| Luo, Y | 1 |
| Mei, X | 1 |
| Tang, J | 1 |
1 other study available for gabexate and Abdominal Injuries
| Article | Year |
|---|---|
Protection Provided by a Gabexate Mesylate Thermo-Sensitive
Topics: Abdominal Injuries; Amylases; Animals; Apoptosis; Ascites; C-Reactive Protein; Edema; Gabexate; Gels | 2017 |